Evidence map›Paper›PMID 21281579›Full record

ArticleBiophysical journal2011

Meconium impairs pulmonary surfactant by a combined action of cholesterol and bile acids.

Elena Lopez-Rodriguez, Mercedes Echaide, Antonio Cruz, H William Taeusch, Jesus Perez-Gil

Open access · bronzeAbstract read
In one paragraph

Article in Biophysical journal, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 54 citations in OpenAlex.

  1. Comparative biophysical study of clinical surfactants using constrained drop surfactometry.American journal of physiology. Lung cellular and molecular physiology · 2024
    Article
  2. Meconium aspiration syndrome: from pathophysiology to treatment.Annals of medicine and surgery (2012) · 2024
    Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Pulmonary surfactant and drug delivery: Vehiculization, release and targeting of surfactant/tacrolimus formulations.Journal of controlled release : official journal of the Controlled Release Society · 2021
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Advances in the management of meconium aspiration syndrome.International journal of pediatrics · 2012
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Elena Lopez-RodriguezDepartamento Bioquimica, Facultad Biologia, Universidad Complutense, Madrid, Spain.
Mercedes EchaideDepartamento Bioquimica, Facultad Biologia, Universidad Complutense, Madrid, Spain.
Antonio CruzDepartamento Bioquimica, Facultad Biologia, Universidad Complutense, Madrid, Spain.
H William TaeuschDepartment of Pediatrics, San Francisco General Hospital, University of California, San Francisco, California.
Jesus Perez-GilDepartamento Bioquimica, Facultad Biologia, Universidad Complutense, Madrid, Spain. Electronic address: jpg@bbm1.ucm.es.
Universidad Complutense de Madrid · ESSan Francisco General Hospital · US

Funding

POLYMER - SURFACTANT THERAPY IN RAT MODELS OF ARDSR01HL066410 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI TAEUSCH, HWILLIAM · 2001 to 2010
$2.3M
NHLBI NIH HHS R01 HL066410NHLBI NIH HHS R01 HL 66410
6 · The paper itself

Abstract

Mechanisms for meconium-induced inactivation of pulmonary surfactant as part of the meconium aspiration syndrome in newborn infants, to our knowledge, are not clearly understood. Here we have studied the biophysical mechanisms of how meconium affects surface activity of pulmonary surfactant and whether the membrane-perturbing effects of meconium can be mimicked by exposure of surfactant to a mixture of bile acids and cholesterol. Surface activity of pulmonary surfactant complexes purified from animal lungs was analyzed in the absence and in the presence of meconium in standard surface balances and in a captive bubble surfactometer. We have also evaluated accumulation of surfactant at the air-liquid interface by what we believe to be a novel microtiter plate fluorescent assay, and the effect of meconium components on surfactant membrane fluidity using Laurdan fluorescence thermotropic profiles and differential scanning calorimetry thermograms. Rapid interfacial adsorption, low surface tension upon film compression, efficient film replenishment upon expansion, and thermotropic properties of surfactant complexes are all adversely affected by meconium, and, in a similar manner, they are affected by cholesterol/taurocholate mixtures but not by taurocholate alone. We conclude that inhibition of surfactant by meconium can be mimicked by a bile salt-promoted incorporation of excess cholesterol into surfactant complexes. These results highlight the potential pathogenic role of cholesterol-mobilizing agents as a crucial factor resulting in cholesterol induced alterations of structure and dynamics of surfactant membranes and films.

Indexed as

AdsorptionAnimalsBile Acids and SaltsCalorimetry, Differential ScanningCholesterolHumansInfant, NewbornMeconiumMembranesPulmonary SurfactantsSpectrometry, FluorescenceSurface PropertiesSus scrofaTemperatureBile Acids and SaltsCholesterolPulmonary Surfactants

Identifiers

PMID21281579
PMCPMC3030210
OpenAlexW2053848941

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.